Overview
Dr. Hamadani is a Professor of Medicine and Chief of Hematologic Malignancies at the Medical College of Wisconsin (MCW) in Milwaukee, WI. He serves as the Associate Director of Clinical Research at the MCW Clinical Cancer Center and holds the Cancer Center Scholar Endowed Chair. Dr. Hamadani graduated with honors from King Edward Medical College (Pakistan), in 2001. He completed internal medicine residency from the University of Oklahoma followed by a fellowship in Hematology/Oncology at The Ohio State University. He is considered an international key opinion leader in the fields of hematopoietic cell transplantation, cellular therapy and lymphoid malignancies. He has authored over 450 peer-reviewed publications. As the Principal Protocol Officer for BMT CTN and Co-PI of MCW LAPS Grant he has extensive experience in clinical trial design and has been involved in the development and execution of several practice changing transplant clinical trials. He chairs the ASTCT Committee on Practice Guidelines and served as the Secretary of American Society for Transplant and Cellular Therapies (2024-26). His key areas of search include graft-versus-host disease (GvHD), developmental therapeutics for lymphoid malignancies and hematopoietic cell transplantation. His clinical expertise includes lymphomas, transplant, and CAR-T cell therapies. He considers mentoring junior faculty and trainees as his top-most priority.
Dr. Hamadani is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Hamadani is board certified in Internal Medicine, Hematology, and Medical Oncology. He is actively involved in clinical research, participating in 1 clinical trial. Dr. Hamadani is currently accepting new patients.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- PPO
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8800 W. Doyne Ave., Milwaukee, WI 53226
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Childrens Hospital Of Wisconsin Inc
Robert Montgomery is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Montgomery is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, Hemophilia B, and Bone Marrow Transplant.
Clinical Cancer Center - Froedtert Hospital
Dr. Anita D’Souza is a professor of medicine (hematology/oncology). She completed her medical school from Goa Medical College, India where she graduated at the top of her class and was awarded Best Medical Graduate. She completed her internal medicine residency from William Beaumont Hospital in Michigan where she received the Zimmerman Award for Outstanding Clinical Judgment, Leadership, and Integrity. She completed her hematology/oncology fellowship from the Mayo Clinic in Rochester, Minnesota. She is a past recipient of the Daniel McCarty Award for Research Excellent and Women in Science Rising Pioneer Award at MCW. Dr. D'souza is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy. Dr. D'souza is board certified in Internal Medicine and Medical Oncology And Hematology. Dr. D'souza is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Binod Dhakal, MD, MS, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in multiple myeloma and plasma cell disorders. He graduated from Manipal College of Medical Sciences, Pokhara Nepal in 2004, completed internal medicine residency at Saint Francis Hospital, Evanston, IL, and a fellowship in hematology/oncology at the Medical College of Wisconsin, where he also served as a chief fellow. Prior to joining the fellowship, he was an assistant professor of medicine (general internal medicine) at the Medical College in Wisconsin. He has authored numerous publications, including journal articles, meeting abstracts and book chapters. He has also won several awards during his fellowship which include the American Society of Clinical Oncology (ASCO) Merit Award; Medical College of Wisconsin Affiliated Hospitals (MCWAH) research award; Central Society for Clinical and Translational Research (CSCTR) best oral abstract and travel trainee award; American Society for Blood and Marrow Transplantation (ASBMT) clinical research training course; and, Outstanding Medical School Teacher award. Additionally, he was the recipient of the Mazie Froedtert Willms and Sue Froedtert Cancer Scholarship, and obtained his Master’s Degree in Clinical and Translational Science. His current research interests focus on novel drug treatments for patients with multiple myeloma and related plasma cell disorders by designing and conducting early phase clinical trials. Dr. Dhakal is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dhakal is currently accepting new patients.
Frequently Asked Questions about Dr. Mehdi H. Hamadani
How do I make an appointment with Dr. Mehdi H. Hamadani?
You can book an appointment with Dr. Mehdi H. Hamadani by calling their office at 414-805-0505. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mehdi H. Hamadani a top-rated expert for Large-Cell Immunoblastic Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mehdi H. Hamadani is classified as an Distinguished expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mehdi H. Hamadani specialize in?
While Dr. Mehdi H. Hamadani is a Hematology, they have specific expertise in Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Mehdi H. Hamadani accept my insurance?
Dr. Mehdi H. Hamadani accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 414-805-0505 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Hamadani isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Hamadani isDistinguished. Learn about Follicular Lymphoma.
- Hodgkin LymphomaDr. Hamadani isDistinguished. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Hamadani isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Multiple MyelomaDr. Hamadani isDistinguished. Learn about Multiple Myeloma.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Hamadani isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Hamadani isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDr. Hamadani isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantDr. Hamadani isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- Adult T-Cell LeukemiaDr. Hamadani isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Hamadani isExperienced. Learn about Agranulocytosis.
- Aleukemic Leukemia Cutis (ALC)Dr. Hamadani isExperienced. Learn about Aleukemic Leukemia Cutis (ALC).
- Anaplastic Large Cell LymphomaDr. Hamadani isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Hamadani isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Aplastic AnemiaDr. Hamadani isExperienced. Learn about Aplastic Anemia.